Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Mini Reviews in Medicinal Chemistry|December 27, 2005
A2B adenosine receptor antagonists: recent developmentsBarbara Cacciari, Giorgia Pastorin, Chiara Bolcato, et al.
Purinergic Signalling|April 12, 2008
Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: A complete structure-activity profileBarbara Cacciari, Chiara Bolcato, Giampiero Spalluto, et al.
Bioorganic & Medicinal Chemistry|March 28, 2006
The application of a 3D-QSAR (autoMEP/PLS) approach as an efficient pharmacodynamic-driven filtering method for small-sized virtual library: application to a lead optimization of a human A3 adenosine receptor antagonistStefano Moro, Magdalena Bacilieri, Barbara Cacciari, et al.
Purinergic Signalling|March 28, 2008
Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: Effect of the N-5 bond type on the affinity and selectivity at the four adenosine receptor subtypesChiara Bolcato, Claudia Cusan, Giorgia Pastorin, et al.
Farmaco (Societa Chimica Italiana : 1989)|April 26, 2005
Synthesis, biological studies and molecular modeling investigation of 1,3-dimethyl-2,4-dioxo-6-methyl-8-(substituted) 1,2,3,4-tetrahydro [1,2,4]-triazolo [3,4-f]-purines as potential adenosine receptor antagonistsGiorgia Pastorin, Chiara Bolcato, Barbara Cacciari, et al.
Purinergic Signalling|April 12, 2008
New 2,6,9-trisubstituted adenines as adenosine receptor antagonists: a preliminary SAR profileCatia Lambertucci, Gloria Cristalli, Diego Dal Ben, et al.
Journal of Chemical Information and Modeling|January 25, 2008
Linear and nonlinear 3D-QSAR approaches in tandem with ligand-based homology modeling as a computational strategy to depict the pyrazolo-triazolo-pyrimidine antagonists binding site of the human adenosine A2A receptorLisa Michielan, Magdalena Bacilieri, Andrea Schiesaro, et al.
Journal of Medicinal Chemistry|March 3, 2006
Synthesis and biological studies of a new series of 5-heteroarylcarbamoylaminopyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as human A3 adenosine receptor antagonists. Influence of the heteroaryl substituent on binding affinity and molecular modeling investigationsGiorgia Pastorin, Tatiana Da Ros, Chiara Bolcato, et al.
Bioorganic & Medicinal Chemistry|June 9, 2009
Combining selectivity and affinity predictions using an integrated Support Vector Machine (SVM) approach: An alternative tool to discriminate between the human adenosine A(2A) and A(3) receptor pyrazolo-triazolo-pyrimidine antagonists binding sitesLisa Michielan, Chiara Bolcato, Stephanie Federico, et al.
Pageof 1